Menu Search
Equities

Venture Life Group PLC

VLG:LSE

Venture Life Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)48.00
  • Today's Change0.00 / 0.00%
  • Shares traded213.69k
  • 1 Year change+50.00%
  • Beta0.2817
Data delayed at least 20 minutes, as of Sep 20 2024 16:37 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Venture Life Group PLC grew revenues 16.89% from 43.98m to 51.41m while net income improved 77.12% from 520.00k to 921.00k.
Gross margin39.19%
Net profit margin1.79%
Operating margin6.40%
Return on assets0.75%
Return on equity1.21%
Return on investment0.93%
More ▼

Cash flow in GBPView more

In 2023, Venture Life Group PLC did not generate a significant amount of cash. However, the company earned 8.22m from its operations for a Cash Flow Margin of 15.99%. In addition the company used 5.34m on investing activities and also paid 2.81m in financing cash flows.
Cash flow per share0.0605
Price/Cash flow per share7.54
Book value per share0.6028
Tangible book value per share0.013
More ▼

Balance sheet in GBPView more

Venture Life Group PLC has a Debt to Total Capital ratio of 24.24%, a lower figure than the previous year's 30.37%.
Current ratio1.08
Quick ratio0.7355
Total debt/total equity0.3199
Total debt/total capital0.2424
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items increased 76.67%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)12.82
EPS (TTM) vs
TTM 1 year ago		52.29
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.